Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NPB-01(Intravenous Immunoglobulin) Maintenance Therapy for Patients With Multifocal Motor Neuropathy.

NCT01827072 is registered in ClinicalTrials.gov with Nihon Pharmaceutical Co., Ltd as lead sponsor.

NCT NCT01827072
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01827072 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NPB-01(Intravenous Immunoglobulin) Maintenance Therapy for Patients With Multifocal Motor Neuropathy.
Lead sponsor
Nihon Pharmaceutical Co., Ltd
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2013
Completion date
June 30, 2015
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multifocal motor neuropathy